Does TREPROSTINIL Cause Injection site discharge? 463 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 463 reports of Injection site discharge have been filed in association with TREPROSTINIL (TYVASO). This represents 0.5% of all adverse event reports for TREPROSTINIL.
463
Reports of Injection site discharge with TREPROSTINIL
0.5%
of all TREPROSTINIL reports
7
Deaths
157
Hospitalizations
How Dangerous Is Injection site discharge From TREPROSTINIL?
Of the 463 reports, 7 (1.5%) resulted in death, 157 (33.9%) required hospitalization, and 6 (1.3%) were considered life-threatening.
Is Injection site discharge Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TREPROSTINIL. However, 463 reports have been filed with the FAERS database.
What Other Side Effects Does TREPROSTINIL Cause?
Dyspnoea (16,348)
Headache (14,051)
Diarrhoea (11,335)
Nausea (10,320)
Cough (8,945)
Fatigue (7,440)
Dizziness (7,405)
Infusion site pain (5,169)
Vomiting (5,097)
Death (4,764)
What Other Drugs Cause Injection site discharge?
ADALIMUMAB (691)
SEMAGLUTIDE (388)
SOMATROPIN (283)
DUPILUMAB (130)
FREMANEZUMAB-VFRM (117)
EXENATIDE (110)
RISANKIZUMAB-RZAA (107)
CORTICOTROPIN (98)
VEDOLIZUMAB (87)
HUMAN IMMUNOGLOBULIN G (85)
Which TREPROSTINIL Alternatives Have Lower Injection site discharge Risk?
TREPROSTINIL vs TREPROSTINIL DIOLAMINE
TREPROSTINIL vs TRETINOIN
TREPROSTINIL vs TRIAMCINOLONE
TREPROSTINIL vs TRIAMCINOLONE ACETONIDE
TREPROSTINIL vs TRIAMCINOLONE HEXACETONIDE